Inflammation Relief has been one of AOR’s most advanced products since it was introduced in 2009; it continues to be the most effective herbal anti-inflammatory available. This multi-ingredient formula features three of Ayurvedic medicine’s most powerful anti-inflammatory herbs: curcumin, boswellia, and ashwagandha. It is ideal for those suffering from painful and degenerative joint conditions such as rheumatoid or osteoarthritis. It is also beneficial for those dealing with systemic inflammation. These traditional herbs have been enhanced through an industry-leading process for better absorption and bio-availability.
Inflammation is a necessary process for the survival of any species during infection and injury. In healthy tissue, a natural balance is restored but, in some cases, the immune system switches modes, resulting in a chronic inflammation that is a feature of many diseases, including auto-immune diseases, Type 1 diabetes, lupus and even certain types of cognitive decline.
The natural anti-inflammatory agents found in Inflammation Relief have been scientifically proven to lower inflammation. They work together, and their benefits are numerous and non-specific, without causing the unwanted side effects of common non-steroidal anti-inflammatory drugs (NSAIDs). Unlike other products, AOR’s Inflammation Relief utilizes Longvida® Optimized Curcumin, developed and patented by UCLA Medical School and proven to be highly bioavailable and well-absorbed.
Inflammation Relief is a multiple-ingredient formula featuring three proven anti-inflammatory herbs optimized for bioavailability and absorption.
|AOR44002||80033401||60 LIQUID CAPS|
|Serving Size: 1 Capsule||Amount|
|Ashwagandha extract (10:1)||33.3 mg|
|Boswellia serrata ( > 40% boswellic acids)||166.5 mg|
|Optimized Curcumin* (from Curcuma longa root)||80 mg|
*LONGVIDA® is a registered trademark of est une marque déposée de Verdure Sciences Inc. International, patent pending/Instance de brevet international.
|Non-medical ingredients: |
oleanolic acid, potato starch, medium chain triglycerides, ascorbyl palmitate, lecithin(soy, sunflower) stearic acid, maltodextrin, silicon dioxide, polysorbate 20. Capsule: hypromellose, chlorophyll.
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, dairy, eggs, fish, shellfish or any animal byproduct.
Take 1 capsule one to three times daily with food, or as directed by a qualified health care practitioner.
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, taking antiplatelet medication or blood thinners, have gallstones, bile duct obstruction, stomach ulcers, excess stomach acid, or if symptoms persist or worsen or for use beyond 6 months. Some people may experience mild gastrointestinal effects such as diarrhea, abdominal pain/cramps and nausea. Discontinue use if hypersensitivity (e.g. allergy) occurs. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.
Curcumin extracts of turmeric are proposed to produce health benefits. To date, human intervention studies have focused mainly on people with existing health problems given high doses of poorly absorbed curcumin. The purpose of the current study was to check whether in healthy people, a low dose of a lipidated curcumin extract could alter wellness-related measures.
The present study was conducted in healthy middle aged people (40-60 years old) with a low dose of curcumin (80 mg/day) in a lipidated form expected to have good absorption. Subjects were given either curcumin (N = 19) or placebo (N = 19) for 4 wk. Blood and saliva samples were taken before and after the 4 weeks and analyzed for a variety of blood and saliva measures relevant to health promotion.
Curcumin, but not placebo, produced the following statistically significant changes: lowering of plasma triglyceride values, lowering of salivary amylase levels, raising of salivary radical scavenging capacities, raising of plasma catalase activities, lowering of plasma beta amyloid protein concentrations, lowering of plasma sICAM readings, increased plasma myeloperoxidase without increased c-reactive protein levels, increased plasma nitric oxide, and decreased plasma alanine amino transferase activities.
Collectively, these results demonstrate that a
low dose of a curcumin-lipid preparation can produce a variety of potentially
health promoting effects in healthy middle aged people.
To demonstrate clinical equivalence between two standardized Ayurveda (India) formulations (SGCG and SGC), glucosamine and celecoxib (NSAID).
Ayurvedic formulations (extracts of Tinospora cordifolia, Zingiber officinale, Emblica officinalis, Boswellia serrata), glucosamine sulphate (2 g daily) and celecoxib (200 mg daily) were evaluated in a randomized, double-blind, parallel-efficacy, four-arm, multicentre equivalence drug trial of 24 weeks duration. A total of 440 eligible patients suffering from symptomatic knee OA were enrolled and monitored as per protocol. Primary efficacy variables were active body weight-bearing pain (visual analogue scale) and modified WOMAC pain and functional difficulty Likert score (for knee and hip); the corresponding a priori equivalence ranges were ±1.5 cm, ±2.5 and ±8.5.
Differences between the intervention arms for mean changes in primary efficacy variables were within the equivalence range by intent-to-treat and per protocol analysis. Twenty-six patients showed asymptomatic increased serum glutamic pyruvic transaminase (SGPT) with otherwise normal liver function; seven patients (Ayurvedic intervention) were withdrawn and SGPT normalized after stopping the drug. Other adverse events were mild and did not differ by intervention. Overall, 28% of patients withdrew from the study.
In this 6-month controlled study of knee OA,
Ayurvedic formulations (especially SGCG) significantly reduced knee pain and
improved knee function and were equivalent to glucosamine and celecoxib. The
unexpected SGPT rise requires further safety assessment.
Arthritis, an inflammation of the joints, is usually a chronic disease that results from dysregulation of pro-inflammatory cytokines (e.g. tumour necrosis factor and interleukin-1beta) and pro-inflammatory enzymes that mediate the production of prostaglandins (e.g. cyclooxygenase-2) and leukotrienes (e.g. lipooxygenase), together with the expression of adhesion molecules and matrix metalloproteinases, and hyperproliferation of synovial fibroblasts. All of these factors are regulated by the activation of the transcription factor nuclear factor-kappaB. Thus, agents that suppress the expression of tumour necrosis factor-alpha, interleukin-1beta, cyclooxygenase-2, lipooxygenase, matrix metalloproteinases or adhesion molecules, or suppress the activation of NF-kappaB, all have potential for the treatment of arthritis. Numerous agents derived from plants can suppress these cell signaling intermediates, including curcumin (from turmeric), resveratrol (red grapes, cranberries and peanuts), tea polyphenols, genistein (soy), quercetin (onions), silymarin (artichoke), guggulsterone (guggul), boswellic acid (salai guggul) and withanolides (ashwagandha). Indeed, several preclinical and clinical studies suggest that these agents have potential for arthritis treatment. Although gold compounds are no longer employed for the treatment of arthritis, the large number of inexpensive natural products that can modulate inflammatory responses, but lack side effects, constitute 'goldmines' for the treatment of arthritis.
All rights Reserved. Copyright © by AOR 2019